Casper Pharma Private Limited
Casper Pharma Private Limited is a Private Indian company incorporated in 2016 and based in Maharashtra, India. Casper Pharma Private Limited operates in Pharmaceuticals & Chemicals (NIC 24233) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Casper Pharma Private Limited is the legal entity of Casper Pharma.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Casper Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +32d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +25d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +19d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Casper Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 229452655 | ICICI Bank Ltd(Bank) | ₹10.84 Cr | 19 Sep 2020 | Open |
| 887403631 | Kotak Mahindra Bank Ltd(Bank) | ₹1.03 Cr | 04 Jul 2019 | Open |
| 233269679 | State Bank of India(Bank) | ₹7.01 Cr | 12 Mar 2022 | Open |
| 287766902 | State Bank of India(Bank) | ₹24.64 Cr | 12 Mar 2021 | Open |
Charge IDs, lenders & amounts for Casper Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹46.83 Cr | ₹7.46 Cr | ₹30.19 Cr | ₹46.19 Cr | 215 |
| FY2023-24 | ₹40.37 Cr | ₹6.19 Cr | ₹24.55 Cr | ₹49.25 Cr | 299 |
| FY2022-23 | ₹32.05 Cr | ₹5.41 Cr | ₹13.18 Cr | ₹34.94 Cr | 32 |
| FY2021-22 | ₹35.76 Cr | ₹6.08 Cr | ₹25.25 Cr | ₹43.26 Cr | 21 |
Audited financials & ratios for Casper Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹46.83 Cr | ₹40.37 Cr | ₹32.05 Cr | ₹35.76 Cr |
| Other income | ₹1.73 Cr | ₹93.55 L | ₹93.45 L | ₹74.48 L |
| Total income | ₹48.55 Cr | ₹41.31 Cr | ₹32.99 Cr | ₹36.50 Cr |
| Total expenses | ₹39.00 Cr | ₹33.39 Cr | ₹26.06 Cr | ₹28.71 Cr |
| Profit before tax | ₹9.70 Cr | ₹8.04 Cr | ₹7.04 Cr | ₹7.91 Cr |
| Profit / (Loss) after tax | ₹7.46 Cr | ₹6.19 Cr | ₹5.41 Cr | ₹6.08 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹30.19 Cr | ₹24.55 Cr | ₹13.18 Cr | ₹25.25 Cr |
| Borrowings | ₹6.39 Cr | ₹9.56 Cr | ₹10.31 Cr | ₹5.68 Cr |
| Current liabilities | ₹8.74 Cr | ₹10.10 Cr | ₹11.58 Cr | ₹7.01 Cr |
| Total liabilities | ₹16.00 Cr | ₹24.70 Cr | ₹21.76 Cr | ₹18.01 Cr |
| Current assets | ₹22.07 Cr | ₹20.30 Cr | ₹17.56 Cr | ₹24.54 Cr |
| Cash & equivalents | ₹8.09 Cr | ₹5.93 Cr | ₹2.62 Cr | ₹8.98 Cr |
| Total assets | ₹46.19 Cr | ₹49.25 Cr | ₹34.94 Cr | ₹43.26 Cr |
| Employees | 215 | 299 | 32 | 21 |
Audited financials & ratios for Casper Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹46.83 Cr | +31.0% | +5.3% | +2.0% |
| Profit after Tax | ₹7.46 Cr | +2.4% | +20.8% | +5.8% |
| Net Worth | ₹30.19 Cr | +26.2% | +6.6% | +16.0% |
| Employees | 215 | +27.1% | +7.2% | +21.7% |
Audited financials & ratios for Casper Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹46.83 Cr | ₹7.46 Cr | +15.94% | +29.06% | +24.72% | +16.16% | 0.21 | ₹21.78 L |
| FY2023-24 | ₹40.37 Cr | ₹6.19 Cr | +15.33% | +31.49% | +25.21% | +12.56% | 0.39 | ₹13.50 L |
| FY2022-23 | ₹32.05 Cr | ₹5.41 Cr | +16.89% | +2.68% | +41.08% | +15.49% | 0.78 | ₹1.00 Cr |
| FY2021-22 | ₹35.76 Cr | ₹6.08 Cr | +17.02% | +21.49% | +24.10% | +14.06% | 0.22 | ₹1.70 Cr |
Audited financials & ratios for Casper Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 80,25,464 | 86.82% |
| Institutional Investors | 2 | 5,57,474 | 6.03% |
| Public & Others | 50 | 6,60,963 | 7.15% |
Promoter, institutional & public holding for Casper Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
382 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.